IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells (Q59632258)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 March 2011
edit
Language Label Description Also known as
English
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
scientific article published on 21 March 2011

    Statements

    IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit